DSP Mutual Fund Crosses 5% Threshold in Syngene International with Fresh Share Acquisition

2 min read     Updated on 10 Apr 2026, 12:30 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

DSP Trustee Private Limited acquired 9,93,389 shares of Syngene International on April 07, 2026, increasing its shareholding from 4.79% to 5.03% and crossing the regulatory threshold requiring SEBI disclosure. The acquisition involved multiple DSP Mutual Fund schemes and was executed through open market transactions, with formal regulatory filing completed on April 09, 2026.

powered bylight_fuzz_icon
37350051

*this image is generated using AI for illustrative purposes only.

Syngene International has witnessed a significant institutional investment as DSP Trustee Private Limited crossed the 5% shareholding threshold through a substantial share acquisition. The transaction, completed on April 07, 2026, involved the purchase of 9,93,389 shares through open market operations, prompting mandatory regulatory disclosures under SEBI takeover regulations.

Acquisition Details and Shareholding Changes

The share acquisition was executed by multiple schemes under DSP Mutual Fund, managed by DSP Asset Managers Private Limited. The participating schemes included DSP Large Cap Fund, DSP Equity Savings Fund, DSP Aggressive Hybrid Fund, DSP Nifty 500 Index Fund, DSP Nifty Healthcare Index Fund, DSP Nifty Smallcap 250 Index Fund, and DSP Nifty Midcap 150 Quality 50 Index Fund.

Parameter Before Acquisition Acquisition After Acquisition
Shares Held 1,92,92,837 9,93,389 2,02,86,226
Shareholding Percentage 4.79% 0.24% 5.03%
Total Share Capital 40,29,39,420 shares - 40,29,39,420 shares

Regulatory Framework and Compliance

DSP Trustee Private Limited acts as the trustee for schemes launched by DSP Mutual Fund and DSP Alternative Investment Fund, with DSP Asset Managers Private Limited serving as the Investment Manager. The entity also manages DSP Global Funds ICAV, with all these entities collectively falling within the definition of persons acting in concert under SEBI regulations.

The acquisition triggered reporting requirements under Section 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as the combined shareholding exceeded the 5% threshold. The formal disclosure was filed on April 09, 2026, by Dr. Pritesh Majmudar, Compliance Officer and Company Secretary at DSP Asset Managers Private Limited.

Transaction Structure and Market Impact

The shares were acquired through ordinary equity transactions in the open market, with no involvement of preferential allotment, rights issues, or other special arrangements. The acquisition represents a 0.24% increase in shareholding, bringing the total stake to 5.03% of Syngene International's paid-up capital of Rs. 4,02,93,94,200.

Entity Details Information
Acquirer DSP Trustee Private Limited
Transaction Date April 07, 2026
Mode of Acquisition Open Market
Promoter Group Status No
PAN Number AAACD3070G

The acquisition demonstrates continued institutional interest in Syngene International, with DSP's various fund schemes collectively building a significant position in the biotechnology company. The transaction was executed across multiple fund categories, including large-cap, hybrid, and specialized index funds, indicating diversified investment strategy across DSP's portfolio management approach.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+2.94%+3.46%+1.51%-36.63%-41.50%-27.73%

Will DSP continue accumulating Syngene shares beyond the 5% threshold, potentially triggering additional regulatory disclosures at 10% or higher levels?

How might this institutional backing influence Syngene's strategic partnerships or expansion plans in the biotechnology sector?

Could DSP's diversified fund participation signal broader institutional confidence that may attract other major investors to Syngene?

like20
dislike

Syngene International Records Rs. 65.17 Crore Block Trade on NSE

1 min read     Updated on 10 Apr 2026, 12:28 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Syngene International executed a major block trade on NSE worth Rs. 65.17 crores, involving 1,606,357 shares at Rs. 405.70 per share. The transaction reflects significant institutional activity and demonstrates continued market interest in the pharmaceutical services company.

powered bylight_fuzz_icon
37349903

*this image is generated using AI for illustrative purposes only.

Syngene International recorded a significant block trade on the National Stock Exchange (NSE) valued at Rs. 65.17 crores. The large-volume transaction demonstrates continued institutional interest in the pharmaceutical services company.

Transaction Details

The block trade involved substantial volume and value, reflecting significant market activity in Syngene International shares.

Parameter: Details
Total Value: Rs. 65.17 crores
Number of Shares: 1,606,357 shares
Price per Share: Rs. 405.70
Exchange: NSE

Market Significance

Block trades are typically executed by institutional investors, mutual funds, or large stakeholders looking to buy or sell substantial quantities without impacting the regular market price. These transactions are conducted outside the normal trading mechanism to ensure minimal market disruption while providing necessary liquidity.

The execution price of Rs. 405.70 per share and the substantial volume of over 1.6 million shares indicates significant institutional participation in Syngene International's stock. Such transactions often reflect strategic portfolio adjustments or investment decisions by large market participants.

About Block Trades

Block trades serve as an important mechanism for large-volume transactions in the Indian equity markets. They allow institutional investors to execute substantial trades efficiently while maintaining market stability and providing price discovery for significant stake transfers.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+2.94%+3.46%+1.51%-36.63%-41.50%-27.73%

Will this large institutional investment signal increased confidence in Syngene's pharmaceutical services growth prospects?

How might this block trade impact Syngene's stock liquidity and trading patterns in the coming weeks?

Could this transaction indicate potential strategic partnerships or collaborations for Syngene International?

like20
dislike

More News on Syngene International

1 Year Returns:-41.50%